Home

The Latest Stories

Anadys Pharmaceuticals says hepatitis C drug candidate shows potential in early study

Anadys Pharmaceuticals Inc. said Tuesday its hepatitis C drug candidate ANA-773 could be extremely effective at treating the diseases. The statement is based on early-stage study data, which is only typically good for studying safety. But, the company said early-stage, or Phase I, data showed the drug candidate ...

Colo. surgery tech linked to hepatitis cases pleads not guilty to painkiller tampering charges

A surgery technician accused of swapping her dirty syringes for ones filled with powerful painkillers meant for patients, possibly exposing thousands of people to hepatitis C, pleaded not guilty to federal charges Thursday. Prosecutors claim Kristen Diane Parker, 26, is linked to at least 19 cases ...

Anadys Pharma says FDA approved mid stage study design for ANA598, and shares advance

Shares of Anadys Pharmaceuticals Inc. climbed Friday after the company said regulators approved the design of a study of a potential hepatitis C treatment. In morning trading, Anadys stock jumped $1.32, or 73.3 percent, to $3.12. More than 13 million shares changed hands ...

Anadys Pharmaceuticals gets FDA clearance to begin study on hepatitis C therapy

Anadys Pharmaceuticals Inc. said Thursday the Food and Drug Administration cleared the company's plan for a midstage study on a potential combination therapy for hepatitis C. The combination includes the drug candidate ANA598, with Interferon-Alpha and Ribavirin. The latter two are already used in combination to treat ...

Both hepatitis C drugs work about the same: study

CHICAGO (Reuters) - Two standard treatments for hepatitis C work equally well at knocking down the virus for most patients, U.S. researchers reported on Wednesday. The findings, from a 3,000-patient comparative effectiveness study, are meant to help guide doctors' decisions about which treatments work best -- an idea at the center of Present Barack Obama's hopes for healthcare reform ...

NY hospital warns of possible hepatitis exposure from tech charged in Colorado cases

A hospital in New York state is notifying about 2,800 patients of possible exposure to hepatitis C after learning that a former employee is suspected of exposing nearly 6,000 patients in Colorado to the disease. The New York State Health Department said Wednesday that it ...

Another hepatitis case linked to Colorado hospital where surgery tech worked; total now 11

Another hepatitis C case has been linked to a Denver hospital where an infected surgery technician is accused of swapping her dirty syringes for ones filled with a powerful painkiller meant for patients. Colorado health officials said Friday that 11 cases are now linked to Rose ...

Painkiller-addicted scrub tech causes hepatitis scare in Colo, unnerving thousands of patients

Kimberly Spencer's 9-year-old son went to Audubon Ambulatory Surgery Center last month for what was supposed to be a routine surgery. The rambunctious child stuck a BB in his ear and doctors had to operate to remove it. What happened next shocked the family. They were notified ...